November 12-13, 2024
Novartis BioMedical Research
Cambridge, MA, USA
November 12-13, 2024
Novartis BioMedical Research
Cambridge, MA, USA
Derek Lowe, Ph.D.
Director in Chemical Biology & Therapeutics
Novartis Institutes for BioMedical Research (United States)
Topic: AI in Biomedicine: What it Can Do For Us, and What It Can Do to Us
With over 27 years of extensive experience in the pharmaceutical industry, Lowe has distinguished himself as a leader in medicinal chemistry and drug discovery. He's held pivotal roles at various companies, including Vertex, Bayer and Schering-Plough, where he served as a medicinal chemistry lab head, project leader and specialist in pioneering drug discovery technologies.
Lowe is a prolific freelance writer who covers science and pharmaceutical topics outside his industrial roles. His insightful columns and articles have been featured in publications such as Chemistry World, Contract Pharma Pharmaceutical Executive and Genome Technology.
Lowe is also the author of the Science.org blog "In the Pipeline," a widely read resource on industry science frequently cited by Forbes, Fortune, The Wall Street Journal and others. The blog is a go-to source for the latest drug discovery and development insights.
His specialties encompass drug discovery research across various therapeutic areas, including oncology, metabolic disease, Alzheimer's and infectious disease.
Photo credit:
Derek Lowe